miércoles, 24 de febrero de 2010

Si el zapato "calza"...

"Price" was exogenous to the marketing mix; constantly increasing in the US, constantly declining in most of the rest of the world. However, soaring healthcare costs have resulted in governments, health services and payers taking an active role to curb this unsustainable trend. These new customers have significant power and in past years have redefined the value of pharmaceutical products.

What's out: innovation.

What's in: outcomes.

Click sobre imagen para ampliar


No hay comentarios: